Biontech SE

NASDAQ:BNTXUnited States

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Contact Information

Headquarters

An der Goldgrube 12MAINZ, Germany 55131

Phone

---

Fax

---

Executives

Independent Chairman of the Supervisory Board

Helmut Jeggle

Chief Executive Officer, Member of the Management Board

Ugur Sahin

Independent Deputy Chairman of the Supervisory Board

Ulrich Wandschneider

Chief Financial Officer

Jens Holstein

Chief Operating Officer, Member of the Management Board

Sierk Poetting